IMPACT OF CLINICAL AND IMMUNOLOGICAL PARAMETERS ON THE FREQUENCY AND PREVALENCE OF HELICOBACTER PYLORI IN PATIENTS WITH RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1995-4484-2017-634-636
Abstract
The article presents the results of an investigation conducted to study the prevalence of Helicobacter pylori (H. pylori) infection in patients with rheumatoid arthritis (RA) in relation to the clinical and immunological features of the disease. Objective: to investigate an association between the gastric mucosal (GM) colonization with H. pylori and the clinical and immunological features of RA. Material and methods. The investigation enrolled 75 patients (8 men and 67 women) aged 20 to 75 years (mean age, 45.5±10.1 years) who were diagnosed with RA. The disease duration was 6 months to 30 years (mean 8.3±6.9 years). H. pylori were detected by a histological method. For this purpose, all the patients underwent esophagogastroduodenoscopy using a PENTAXEKP 1000 endoscope (Japan). During endoscopic examination, targeted biopsy was performed, by taking multiple GM biopsy specimens. The degree of H. pylori contamination was compared in patients with seropositive and seronegative RA, as well as depending on the presence or absence of anti-cyclic citrullinated peptide (anti-CCP) antibodies. Results and discussion. The results of the investigation may lead to the conclusion that there is a relationship between the contamination with H. pylori and the immunological manifestations of RA. A direct correlation was found between the prevalence of H. pylori infection and the presence of anti-CCP antibodies. There was also a trend toward the increased spread of H. pylori in patients with seropositive RA as compared to those with seronegative RA.
About the Authors
Sh. F. GadievaAzerbaijan
Internal Diseases Department Four
S. K. Musaev
Azerbaijan
Internal Diseases Department Four
References
1. Диагностика и лечение хеликобактерной инфекции. Рекомендации третьей конференции Европейской группы по изучению Нр 2005. Клиническая фармакология и терапия. 2006;(12):32-5 [Diagnosis and treatment of Helicobacter pylori infection. Recommendations of the third conference of the European Group for the Study of HP 2005. Klinicheskaya Farmakologiya i Terapiya. 2006;(12):32-5 (In Russ.)].
2. Boukthir S, Mrad M, Kalach A, et al. Gastricatrophy and Helikobacter pylori infection. J Gastroenterol. 2009;30(2):107-9.
3. Moriyama T, Matsumato T, Fuehigami T, et al. Changes in Helicobakter pylori status in patients with rheumatoid arthritis under non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 2004;39(2):111-8. doi: 10.1080/00365520310008089
4. Giral A, Erdoqan M, Celikel CA, et al. Effect of Helicobacter pylori eradication on antithrombatic dose aspirin-induced gastro-duodenal mucosal injury. Gastroenterol Hepatol. 2004;19(7):773-7. doi: 10.1111/j.1440-1746.2004.03374.x
5. Brozozowski T, Konturek SJ, Pawlik WW. Nonsteroidal anti-inflammatoru drugs and Helicobacter pylori in the stomach: synergism, antogonism or independens? Gastroenterol Hepatol. 2006;13(4):233-7.
6. Ярмоло ТИ. Эффективность применения амизона и локальной околосуставной терапии для профилактики НПВС-гастропатии у ревматических больных: Автореф. дисс. …. канд. мед. наук. 2004. 20 с. [Yarmolo TI. Effektivnost' primeneniya amizona i lokal'noi okolosustavnoi terapii dlya profilaktiki NPVS-gas-tropatii u revmaticheskikh bol'nykh: Avtoref. diss. …. kand. med. nauk [Efficacy of amizone and local periarticular therapy for the prevention of NSAID-gastropathy in rheumatic patients: Author's abstract. diss. .... cand. med. science. 2004. 20 p.].
7. De Leest HT, Steen RS, Bloemena E, et al. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis a randomized controlled trial. J Clin Gastroenterol. 2009;43(2):140-6. doi: 10.1097/MCG.0b013e3181595b40
8. Sebesi J, Siming M, Taller A. Gastrointestinal mucosal lesions in Helicobacter pylori positive and neqativ patients treated with NSAIDs. Degestion. 1998;59 Suppl 3:217.
9. Бзарова ТМ, Алексеева ЕИ и др. Лечение патологии верхних отделов ЖКТ у детей с ревматическими болезнями. Вопросы современной педиатрии. 2006;(2):33-8 [Bzarova TM, Alekseeva EI, et al. Treatment of pathology of the upper gastrointestinal tract in children with rheumatic diseases. Voprosy Sovremennoi Pediatrii. 2006;(2):33-8 (In Russ.)].
10. Smuk DS, Koutsompas AL, Mutilinau MG, et al. Helicobacter pylori and autoimmune disease: Cause of bystander. World J Gastroenterol. 2014;20(1): 613-23. doi: 10.3748/wjg.v20.i3.613
11. Герман ЕБ. Клинико-инструментальная и морфологическая характеристика верхних отделов желудочно-кишечного тракта при ювенильном ревматоидном артрите и коррекция выявленных нарушений: Дисс. … канд. мед. наук. Киев, 2012 [German EB. Kliniko-instrumental'naya i morfologicheskaya kharakteristika verkhnikh otdelov zheludochno-kishechnogo trakta pri yuvenil'nom revmatoidnom artrite i korrektsiya vyyavlennykh narushenii: Diss. … kand. med. nauk [Clinical and instrumental and morphological characteristics of the upper sections of the gastrointestinal tract in juvenile rheumatoid arthritis and correction of revealed disorders: Diss. ... cand. med. sciences]. Kiev, 2012].
12. Вязникова ОА. Синдром диспепсии и патология верхних отделов желудочно-кишечного тракта у больных ревматоидным артритом: Автореф. дисс. … канд. мед. наук. Нижний Новго-род; 2008. 28 с. [Vyaznikova OA. Sindrom dispepsii i patologiya verkhnikh otdelov zheludochno-kishechnogo trakta u bol'nykh revmatoidnym artritom: Avtoref. diss. … kand. med. nauk [Syndrome of dyspepsia and pathology of the upper gastrointestinal tract in patients with rheumatoid arthritis: Author's abstract. diss. ... cand.
13. med. sciences]. Nizhnii Novgorod; 2008. 28 p.].
14. Cetts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders triggering of autoimmune diseases by infections. Clin Exp Immun. 2010;15:211.
15. Suleymanov ZM, Hidayatov AH, Musayev SR. Helicobacter pylori – ya bagli antral gastrit fonunda inkisaf eden onikibarmag bagirsagin xora xesteliyi. Baki: Tedris vesaiti; 2006.
Review
For citations:
Gadieva Sh.F., Musaev S.K. IMPACT OF CLINICAL AND IMMUNOLOGICAL PARAMETERS ON THE FREQUENCY AND PREVALENCE OF HELICOBACTER PYLORI IN PATIENTS WITH RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2017;55(6):634-636. (In Russ.) https://doi.org/10.14412/1995-4484-2017-634-636